Satpathology Profile Banner
Ansu Satpathy Profile
Ansu Satpathy

@Satpathology

Followers
4K
Following
2K
Media
22
Statuses
1K

immunotherapy, genomics, data, cancer @Stanford @Wing_VC @GladstoneInst @CartographyBio @Immunaitech @joinprox @parkerici

Joined July 2015
Don't wanna be here? Send us removal request.
@Satpathology
Ansu Satpathy
18 days
I think Brian is talking to Biotech.
@jaltma
Jack Altman
18 days
"You don't want to be jumping to the hot new thing every time something runs up. The companies that do the best are started typically by people who did when it wasn't cool."
0
0
8
@Satpathology
Ansu Satpathy
20 days
RT @dhaliwas: Financing news! Excited to share that @AmplifyPartners has led a $30M financing for @tahoe_ai - the latest project in our gr….
0
6
0
@grok
Grok
4 days
Join millions who have switched to Grok.
196
397
3K
@Satpathology
Ansu Satpathy
1 month
Clone tracing T cell responses in cancer (using TCR-seq methods) has been incredibly valuable for understanding immunotherapy response and opportunities. A holy grail for us has been thinking about to achieve this for innate immune responses in human cancer - with high accuracy.
@vincentzliu
Vincent Liu
1 month
For innate immune cells, the lack of diverse receptor rearrangements has prevented the study of clonal evolution of the innate immune system in human tissues and tumors. With @satpathology and @caleblareau, I’m delighted to share my PhD work that tackles this challenge:.
2
4
45
@Satpathology
Ansu Satpathy
1 month
I am a strong believer that depth of data can be just as powerful as scale of data. Deep analysis of small groups of humans, and even individuals, can lead to novel biological insights and principles. Today I am the guinea pig. In my own blood, @CalebLareau finds strong evidence
Tweet media one
3
27
237
@Satpathology
Ansu Satpathy
1 month
RT @aaronmring: T cells do the heavy lifting when it comes to the anti-tumor action of checkpoint immunotherapy. But do antibodies play a r….
0
110
0
@Satpathology
Ansu Satpathy
2 months
this is such an interesting paper - suggests that the immune system may be a major (and tractable) target for aging intervention. the brain - immune interaction is also interesting, given findings from several groups that have shown replacement of brain microglia by peripheral.
@hammy_oh
Hamilton Oh
2 months
I'm thrilled to share our new study out in @NatureMedicine! We show that a blood test can estimate how aged or youthful one’s organs are and that these organ ages predict future disease and lifespan. Final paper from my PhD in the @wysscoray lab. 🧵1/12.🔗
0
2
29
@Satpathology
Ansu Satpathy
3 months
RT @euanashley: Atul Butte died yesterday. The world lost a giant. A big bear of a man. With a huge smile. With love for everyone. With ene….
0
86
0
@Satpathology
Ansu Satpathy
3 months
RT @CancerResearch: 🌟 Meet the 2025 Lloyd J. Old STARs- five extraordinary rising scientific leaders whose work is pushing the boundaries o….
0
2
0
@Satpathology
Ansu Satpathy
3 months
RT @ScienceKyle: 🚨 New Preprint 🚨 .A continuous landscape of signaling encodes a corresponding landscape of CAR T cell phenotype. How can w….
0
57
0
@Satpathology
Ansu Satpathy
3 months
RT @AAMortazavi: The general public would think we’re absolutely nuts… derisking is one thing but this is ridiculous $xbi .
0
20
0
@Satpathology
Ansu Satpathy
3 months
Awesome to have @JSheltzer at Stanford!.
@JSheltzer
Jason Sheltzer
3 months
I’m thrilled to share that I’m joining the faculty at the Stanford University School of Medicine. My lab and I will be relocating to Stanford this summer!
Tweet media one
1
0
5
@Satpathology
Ansu Satpathy
3 months
RT @LNuzhna: About a year ago I thought how it must be nice to be building a company working with known tx modality going after known targe….
0
1
0
@Satpathology
Ansu Satpathy
3 months
RT @HutchInnovation: We are pleased to share our work evaluating some of the latest single-cell platforms, including updated chemistries, i….
0
11
0
@Satpathology
Ansu Satpathy
3 months
RT @srikosuri: Solving the "replication crisis" is dumb because (1) it's not a crisis, (2) the medicine is worse than the disease. Much of….
0
60
0
@Satpathology
Ansu Satpathy
3 months
RT @BowTiedBiotech: @Aaron51687924 @AppleHelix If antigen expression is tightly restricted and tumor-specific, like KLK2 versus PSMA, then….
0
1
0
@Satpathology
Ansu Satpathy
3 months
awesome clone tracing method and story from @AlejoFraticelli and colleagues.
@AlejoFraticelli
Alejo Rodriguez-Fraticelli, PhD
3 months
Absolutely thrilled to share with you the final version of EPIclone, out now (open access) in @Nature. This has been an amazing collaboration with the lab of Lars Velten (@larsplus) at @CRGenomica .
0
1
3
@Satpathology
Ansu Satpathy
3 months
I once quit a study section mid-review because a reviewer gave an exceptionally productive physician-scientist trainee (after 15 years of training) a non-fundable K08 score because of small deficiencies in their animal protocol. He said he was being 'fair.' I yelled at him and.
@JTLonsdale
Joe Lonsdale
3 months
The NIH is broken. Much of $50 billion a year funds bureaucracy, political nonsense, and academic welfare instead of breakthrough science. America needs to slash the red tape, fund bold ideas, and stop rewarding mediocrity if we want to lead the next golden age of science. 🧵
Tweet media one
13
11
134
@Satpathology
Ansu Satpathy
4 months
congratulations to @jacobkimmel @byersblake and team - great to see people driving hard towards innovative medicines!.
@byersblake
Blake Byers
4 months
We’ve raised a $130 million Series B led by @kleinerperkins alongside new investors @natfriedman/@danielgross , @vkhosla, and @humancapital — joined by existing investors @foundersfund , @_DimensionCap, and @brian_armstrong (yes, the cofounders are doubling down). We also raised.
0
0
2